中国医疗器械信息
中國醫療器械信息
중국의료기계신식
CHINA MEDICAL DEVICES INFORMATION
2013年
7期
66-70
,共5页
体外反搏%冠心病%缺血总负荷%心率变异性%动态心电图
體外反搏%冠心病%缺血總負荷%心率變異性%動態心電圖
체외반박%관심병%결혈총부하%심솔변이성%동태심전도
enhanced external counterpulsation%coronary heart disesse%total ischemia burden%heart rate variability%dynamicelectrocardiogram
目的:应用动态心电图观察与评价体外反搏对冠心病患者心肌缺血总负荷(TIB)及心率变异性(HRV)的影响。方法:随机将70例冠心病心肌缺血患者分为两组,其中35例在常规药物基础上加用体外反搏治疗为体外反搏组,其他35例应用常规药物治疗为常规治疗组。另选择35名年龄、性别相匹配的健康人作为对照组。治疗前后进行动态心电图检测,对心肌缺血及心率变异的相关指标作对比观察。结果:治疗12周后,症状性与无症状性ST段压低的次数及其持续时间,体外反搏组与常规治疗组均有明显减少及缩短,TIB亦明显降低,与治疗前比较,两组均有显著性差异(均 P<0.01),组间比较体外反搏组疗效优于常规治疗组(P<0.01)。结论:体外反搏疗法对冠心病患者不仅能降低心肌缺血总负荷,而且有改善其心率变异性的作用。
目的:應用動態心電圖觀察與評價體外反搏對冠心病患者心肌缺血總負荷(TIB)及心率變異性(HRV)的影響。方法:隨機將70例冠心病心肌缺血患者分為兩組,其中35例在常規藥物基礎上加用體外反搏治療為體外反搏組,其他35例應用常規藥物治療為常規治療組。另選擇35名年齡、性彆相匹配的健康人作為對照組。治療前後進行動態心電圖檢測,對心肌缺血及心率變異的相關指標作對比觀察。結果:治療12週後,癥狀性與無癥狀性ST段壓低的次數及其持續時間,體外反搏組與常規治療組均有明顯減少及縮短,TIB亦明顯降低,與治療前比較,兩組均有顯著性差異(均 P<0.01),組間比較體外反搏組療效優于常規治療組(P<0.01)。結論:體外反搏療法對冠心病患者不僅能降低心肌缺血總負荷,而且有改善其心率變異性的作用。
목적:응용동태심전도관찰여평개체외반박대관심병환자심기결혈총부하(TIB)급심솔변이성(HRV)적영향。방법:수궤장70례관심병심기결혈환자분위량조,기중35례재상규약물기출상가용체외반박치료위체외반박조,기타35례응용상규약물치료위상규치료조。령선택35명년령、성별상필배적건강인작위대조조。치료전후진행동태심전도검측,대심기결혈급심솔변이적상관지표작대비관찰。결과:치료12주후,증상성여무증상성ST단압저적차수급기지속시간,체외반박조여상규치료조균유명현감소급축단,TIB역명현강저,여치료전비교,량조균유현저성차이(균 P<0.01),조간비교체외반박조료효우우상규치료조(P<0.01)。결론:체외반박요법대관심병환자불부능강저심기결혈총부하,이차유개선기심솔변이성적작용。
Objective: It is observe the influence of enhanced external counterpulsation (EECP) on total ischemia burden (TIB) and heart rate vai ability(HRV) in patients with coronary heart disease(CHD) using Dynamiceletrocardiogram. Methods: seventy CHD patients were randomly into EECP group (n=35)and routine group (n=35). The routine group was treated with normal treatment aspirin, metoprolol, sorbitrate and pravastatin, the EECP group was treated with EECP besed on the normal treatment. The changes of TIB and HRV were observed by Dynamicelectrocardiogram before and after treatment, and were compared with that in 35 healthy people (control group). Results: Frequency and sustained time of ST stage depression, and TIB with symptom and asymtom were decreased significantly (P<0.01 respectively i) in two groups after therapy of 12 weeks, but it decreased more significantly (P<0.01) in EECP group than in routine group. Conclusion: EECP therapy not only reduces TIB but also improves HRV in CHD patients.